Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment

Not yet recruitingOBSERVATIONAL
Enrollment

420

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2035

Conditions
EpilepsySeizure
Interventions
OTHER

Vascuar risk factor screening (blood pressure, medical history, BMI, laboratory tests)

"The vascular risk assessment is outlined below, there may be slight variations according to local routines. Overall, the screening should include:~Family history of vascular disease~Tests/examinations (order or obtain from medical records \[past 3 months\]) Weight Height Waist circumference 12-lead ECG Resting and standing blood pressure Total cholesterol HDL cholesterol LDL cholesterol HbA1c High sensitivity CRP Serum creatinine Urine albumin-to-creatinine ratio~Medical history Atherosclerotic cardiovascular disease Atrial fibrillation Congestive heart failure Diabetes mellitus Hypertension Kidney disease Life-style risk factors (smoking, exercis"

Trial Locations (1)

Unknown

Södra Älvsborg Sjukhus, Borås

All Listed Sponsors
collaborator

Sodra Alvsborgs Hospital

OTHER

collaborator

Skane University Hospital

OTHER

collaborator

Danderyd Hospital

OTHER

collaborator

Uppsala University Hospital

OTHER

lead

Sahlgrenska University Hospital

OTHER

NCT07116330 - Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment | Biotech Hunter | Biotech Hunter